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Sequencing of the Drosophila genome has revealed that there are
‘‘silent’’ homologues of many important genes—family members
that were not detected by classic genetic approaches. Why have so
many homologues been conserved during evolution? Perhaps each
one has a different but important function in every system.
Perhaps each one works independently in a different part of the
body. Or, perhaps some are redundant. Here, we take one well
known gene family and analyze how the individual members
contribute to the making of one system, the tracheae. There are
seven DWnt genes in the Drosophila genome, including wingless
(wg). The wg gene helps to pattern the developing trachea but is
not responsible for all Wnt functions there. We test each one of the
seven DWnts in several ways and find evidence that wg and DWnt2
can function in the developing trachea: when both genes are
removed together, the phenotype is identical or very similar to that
observed when the Wnt pathway is shut down. DWnt2 is ex-
pressed near the tracheal cells in the embryo in a different pattern
to wg but is also transduced through the canonical Wnt pathway.
We find that the seven DWnt genes vary in their effectiveness in
specific tissues, such as the tracheae, and, moreover, the epidermis
and the tracheae respond to DWnt2 and Wg differently. We
suggest that the main advantage of retaining a number of similar
genes is that it allows more subtle forms of control and more
flexibility during evolution.
Comparison of sequences within gene families shows that it isusually the genetically identified members of the family that
are most conserved between different groups of organisms (1).
An example is the Wnt gene family (2). Wnt genes act in many
different developmental processes; in vertebrates, some Wnts are
oncogenes (reviewed in refs. 3 and 4). The Wnt family is ancient
and ‘‘underwent much of its expansion before the divergence of
the arthropod and chordate lineages’’ (5), so that each lineage
still has related groups of paralogues. Of the seven DWnt
Drosophila genes, only one member, wg, is well known. In
vertebrates (at least 15 Wnt genes in the human genome), the
orthologue of wg, Wnt1 was identified as an oncogene by ectopic
expression (6, 7). In Drosophila, none of the other homologues
was discovered in screens that detect mutant phenotypes; in-
stead, they were identified by means of their molecular homology
(‘‘reverse genetics’’). Indeed, even now mutants for only DWnt2
are available; this gene is required for the development of the
male reproductive tract (8). Understanding of the remaining
DWnt genes has depended on patterns of expression or pheno-
types caused by overexpression (9–16), and, therefore, it is not
clear what functions they have in the wild type. For more
information and for a sequence comparison, visit the Wnt page
(http:www.stanford.edurnussewntwindow.html). Current
experiments on Drosophila suggest that the wg gene is respon-
sible for many of the Wnt functions (reviewed in refs. 2 and 17).
If so, one can ask, are the silent homologues idle or redundant?
And if they are ineffective, why have they survived unscathed
during evolution?
Here, we use the tracheal system of Drosophila and assess its
reaction to all members of the DWnt family. We confirm that wg
is indispensable (18, 19) but find that one homologue, DWnt2,
may assist Wg to specify the main tracheal trunk. We present
evidence that tracheal cells are primed to respond differently to
the seven DWnt proteins, of which Wg and DWnt2 both are
made near the tracheal primordia at the appropriate time (18,
19). We find that DWnt2 affects the tracheal development but,
apparently, has no effect on the cuticle, whereas Wg can
influence both.
Materials and Methods
Drosophila Strains and Genetics. The following amorphic or loss-
of-function alleles were used: wgCX4 (ref. 20; referred to else-
where as wg); Df(2L)RF (21); armXM19 (22); fzH51 (23); fz2C1
(24); DWnt2EMSO, DWnt2EMSO-II (a cleaned DWnt2EMSO allele),
DWnt2EMS80P(w, 47A), DWnt2EMSK, DWnt2EMSI, and Df(2R)11
(8). The different DWnt2 alleles were crossed inter se (referred
to elsewhere as Dwnt2 combinations). In embryos carrying
these combinations, there is a mild tracheal phenotype: typically
embryos (4–40%) show a gap in the most anterior part of the
dorsal trunk (DT). However, and confusingly, gaps also are
found in embryos only heterozygous for the same mutant alleles
usually, but not always, in a lower percentage. Therefore, we
were unable to decide whether this phenotype is caused by
dysfunction in the DWnt2 gene. The phenotype of Dwnt2 was
not significantly altered in wg/ background. The double mu-
tants for wg and Dwnt2, referred to as wgDWnt2, were
recombinants of wgCX4 and different DWnt2 alleles. Recombi-
nants of wgCX4 and DWnt2EMSO-II, DWnt2EMS80P(w, 47A) and
Df(2R)11 in homozygous or transheterozygous conditions pro-
duced the phenotypes described in the text. However, recombi-
nants of wgCX4 and DWnt2EMSO, DWnt2EMSI, and DWnt2EMSK
produced embryos with no DT in 100% of hemisegments.
Genetic analysis points to the presence of a dominant modifier
in the original chromosome in which the alleles of the second
EMS mutagenesis in (8) were induced.
The P(lacZ) trachealess enhancer trap line 1-eve-1 was used to
follow the tracheal cells (25).
To remove the maternal contribution, germ-line clones were
induced with the FRTFLPovoD method (26). Females carry-
ing a doubly mutant chromosome fzH51fz2C1FRT2A
ovoD1FRT2A were heat-shocked at 37°C for 1 h in second- or
third-instar larvae.
The following UAS lines were used: UASwg (27), UASarm*
(28), UASDWnt4 (12), andUASDWnt2, UASDWnt4, UASDWnt5,
UASDWnt6, UASDWnt8, and UASDWnt10 (Gary Struhl, unpub-
lished work).
The Gal4 lines used were: btlGal4 (which drives the expression
of UAS constructs in the tracheal cells from stage 11; ref. 29);
wgGal4 (30); ptcGal4 (31); 1407Gal4 (32); armGal4, and
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armFRTGal4VP16 (33). To maximize the efficacy of the Gal4
UAS system, the embryo collections were done at 29°C.
To identify mutant embryos, we used ‘‘blue balancers’’ of the
first, second, and third chromosomes: FM7 ftz-lacZ; CyO hb-lacZ
or CyO ftz-lacZ; and TM3 ftz-lacZ.
Embryo Fixation and Staining. For horseradish peroxidase (HRP)
histochemistry, embryos were fixed in 100 mM Pipes2 mM
EGTA1 mM MgSO4-formaldehyde for 20–30 min and stained
with the Vectastain-ABC kit (Vector Laboratories) according to
standard protocols. The mouse monoclonal mAb2A12 (devel-
oped by N. Patel and C. Goodman and obtained from the
Developmental Studies Hybridoma Bank) was used at 1:5 to
stain the lumen of the tracheal system from stage 1314 onwards.
The rabbit anti-Spalt (from R. Schuh, Max Planck Institute,
Goettingen, Germany) was used at 1:30. The rabbit anti-
galactosidase (Cappel) was used at 1:1,000 to 1:1,500 to detect
tracheal markers and blue balancers. The purified mouse mono-
clonal anti-Wingless (Development Studies Hybridoma Bank,
Iowa City) was used at 1:200. The guinea pig anti-Knirps
(developed by J. Reivitz and provided by M. Ruiz-Gomez,
Centro Biologia Molecular Severo Ochoa, Madrid) was used at
1:1,000. The rabbit anti-DWnt3 (kindly provided by F. Mourkioti
and H. Ja¨kcle, Max Planck Institute) was used 1:50. Biotinylated
or Cy3-, FITC-, and Cy5-secondary antibodies (Jackson Immu-
noResearch) were used at 1:300. To optimize double stainings,
embryos were first stained in black with NiCl2 and then in brown.
Antisense RNA probes were synthesized from cDNA clones of
wg (from J. Bolivar, Univ. of Cadiz, Cadiz, Spain); DWnt2 (from
R. Nusse, Stanford University, Stanford, CA); DWnt4, DWnt6,
DWnt10 (from E. Wilder, Univ. of Pennsylvania, Philadelphia);
DWnt3 (from F. Mourkioti, Max Planck Institute); and dpp
(from I. Alvarez, Harvard University, Cambridge, MA). A DNA
probe was synthesized from a cDNA clone of DWnt8 (from G.
Struhl, Columbia University, College of Physicians and Sur-
geons, New York). Whole-mount in situ hybridization and
antibody staining were performed as described (34) with minor
modifications. Fluorescent in situ hybridization, with tyramide
signal amplification (NEN Life Science), were performed ac-
cording to (35) and followed by antibody staining.
Embryos were observed and photographed with a Zeiss
Axiophot or with an MRC Bio-Rad 1024 confocal microscope.
Embryos were staged according to (36). Images were pro-
cessed in Adobe PHOTOSHOP.
Results and Discussion
DWnt proteins bind as ligands to a family of receptor proteins
{four Frizzled (Fz) homologues in Drosophila, of which Fz and
Fz2 are the most important (24, 37) and act through a cascade
of genes [e.g., disheveled, armadillo (arm), pangolin] on the
nucleus (reviewed in refs. 38–43)}. If, therefore, Wg is the only
ligand acting from the outside of the cell on the receptors, the
wg phenotype should be identical to the phenotype when fz and
fz2 are removed—in some organs, this is so (24, 37). However,
in the trachea, although removal of the two receptor proteins
(Fig. 1B) or one of the intracellular proteins in the cascade
eliminates all DT; removing only Wg leaves some DT intact (refs.
18 and 19; Fig. 1C). Therefore, it seems that another molecule,
presumably a DWnt, acts through the canonical Wnt pathway to
build DT. We now ask, which DWnt is responsible?
Overexpression of Seven DWnts and Removal of Four of Them.
Overexpression of wg or other downstream elements of the Wnt
pathway in the tracheal cells results in increased DT at the expense
of the VB (refs. 18 and 19; Fig. 1E). To investigate further, we
overexpressed each one of the seven DWnts locally in the embryonic
trachea in a normal background. Overexpression of five DWnt
genes (DWnt5, -4, -6, -8, and -10) had no detectable effects; indeed,
the flies were viable, fertile, and seemed normal. This experiment
suggests that the tracheae are not particularly sensitive to these five
proteins. To check whether these proteins are made properly and
can function, they were tested in other assays. DWnt6 and DWnt8
were able to affect tracheal development in a sensitized background
(see below). DWnt5 produced a phenotype in the ventral nerve cord
when expressed with the neural specific driver 1407Gal4, in agree-
ment with the phenotype produced by an HS-DWnt5 line (11).
Moreover, we detected protein expression in the tracheae when
DWnt5 was expressed in tracheal cells (data not shown). DWnt4
produced ectopic denticles in the ventral epidermis when overex-
pressed with armGal4, and the flies died as pharate adults, showing
several defects in the wings when crossed to ptcGal4 (data not
shown). These phenotypes have been described by using a different
UASDWnt4 line (12, 13). We have not been able to find any
noticeable phenotype when overexpressing DWnt10 in several
structures, and, thus, the activity of this line awaits confirmation.
However, we removed DWnt10 together with three other DWnts
(DWnt4, -6, and wg) in Df(2L)RF embryos (ref. 15; see Flybase at
http:flybase.bio.indiana.edu) and found a similar phenotype to
wg, there still being some DT (ref. 18; Fig. 1D). This experiment
argues that at least zygotic DWnt 4, -6 and -10 do not have a
significant function in the trachea under normal conditions. How-
ever, overexpression of DWnt2 locally in the tracheal cells did affect
its development in a similar way to that of wg, producing an excess
of DT cells and DT material at the expense of the VB (Fig. 1F).
These tracheae were defective; they failed to fill with air and the
flies died as embryos and young larvae. This result suggests that
both wg and DWnt2 act or can act in the developing trachea.
DWnt2 Is Produced Near the Tracheal Cells. The expression pattern
for DWnt2 has been described (16). However, we looked closely at
this pattern with respect the tracheal cells. The tracheal placodes
are specified by stage 10 in a specific part of the dorsal ectoderm
Fig. 1. The Wnt pathway is required for tracheal development. Lateral views
of embryos at late stages of embryogenesis stained with mAb2A12 to high-
light the lumen of the tracheae. In all of the figures, anterior is to the left and
dorsal is above. (A) Wild-type embryo. DT, dorsal trunk (arrow); VB, visceral
branch (arrowhead). (B) fzfz2 germ-line clones. The DT is completely miss-
ing apart from minute vestiges of DT material found in the posterior part. (C)
wg, a substantial amount of DT is formed (arrow). (D) Df(2L)RF, a similar
phenotype to wg is observed (arrow points to DT). (E) Ectopic expression of
wg in all tracheal cells—note hypertrophy of DT (arrow). (F) Ectopic expression
of DWnt2 in all tracheal cells—note hypertrophy of DT (arrow).
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and express several markers such as trachealess (44, 45). The results
with DWnt2 are suggestive: it is expressed close to and dorsal to the
tracheal placode by stage 10 and early stage 11 but later disappears
(Fig. 2 A and B).
The spalt (sal) gene (coding for a transcription factor) is
expressed in the dorsal ectoderm, including some tracheal cells,
during stage 10 and persists later in those tracheal cells that form
the DT (ref. 46; Fig. 2 A–D, F). sal is absolutely required for DT
formation (46) and is thus a good marker for DT cell identity.
The most dorsal cells that express sal also coexpress DWnt2 (Fig.
2A). The pattern of wg expression differs strikingly from that of
DWnt2 (refs. 18, 19, and 47; Fig. 2 C–F), although both gene
products are made near the tracheal cells. In arm mutants, Sal
is not expressed in tracheal cells (18, 19) and no DT is formed,
suggesting that sal expression in tracheal cells depends on activation
of the Wnt pathway. Thus, sal could be induced in the tracheal cells
wherever either Wg or DWnt2 proteins are received.
The Function of DWnt2. The above results suggest that wg and
DWnt2, made near the tracheal cells, together sponsor DT
formation. We have more evidence supporting this hypothesis:
in wg embryos, some DT is still formed (Fig. 1C). However, the
tracheal phenotype of wgDWnt2 embryos is significantly
different from that of wg embryos: in 40–45% of hemiseg-
ments, the DT is completely missing (Fig. 3A), and in the
remaining 55–60%, only some reduced and thin DT forms (Fig.
3B). Interestingly, in practically all hemisegments of Df(2L)RF
DWnt2 embryos, the DT is completely missing (data not
shown), indicating that other DWnts account for these traces of
DT (see below). Nevertheless, wgDWnt2 double-mutant em-
bryos are very similar (Fig. 3B) or indistinguishable (Fig. 3A)
from fzfz2 embryos (Fig. 1B), suggesting that wg and DWnt2
sponsor virtually all DT formation.
Removal of Wg and DWnt2 proteins (in wgDWnt2 em-
bryos) eliminates detectable expression of sal in the presumptive
tracheal cells of the DT (Fig. 3 E and H), whereas in wg
embryos, very low levels of sal still can be detected in some
embryos (Fig. 3 F and I). The early expression of sal in the dorsal
ectoderm still is observed in both wg and wgDWnt2 embryos
(data not shown). In wgDWnt2 embryos, late kni expression in
tracheal cells is normal (Fig. 3 L and M), as is the case in arm
mutants (18, 19). In addition, dpp expression also is normal (Fig.
3 J and K)—Dpp has been shown to inhibit sal expression by
activating kni in tracheal cells (48). Thus, the lack of sal must be
caused by the absence of direct or indirect stimulation by the
DWnt pathway and not to repression by the Dpp pathway.
Does DWnt2 act through the canonical Wnt pathway? It
seems so, because the ectopic effects of DWnt2 protein are
blocked in embryos that lack the arm gene (Fig. 4A). Moreover,
in wgDWnt2 embryos, the DT can be substantially rescued by
expressing a constitutively active form of Arm in the tracheal
cells (Fig. 4B). Also, the tracheal phenotype of porcupine (por)
mutants (18) is very similar to that of wgDWnt2 embryos,
indicating that por also might be required for DWnt2 secretion.
If DWnt2 sponsors at least part of DT formation, one might
expect that loss of DWnt2 alone would affect trachea in some
noticeable way. Surprisingly, DWnt2 embryos and larvae have
normal trachea (Fig. 3C) and normal expression of sal (data not
shown). However, the flies have reduced viability (our results)
and the males are sterile (8).
Interdependence of DWnt2 and wg. In normal embryos, the wg gene
is expressed in a row of cells at the rear of the A compartment,
whereas DWnt2 is expressed at the front. Wg protein spreads to
make a gradient that patterns the anterior compartment (49, 50).
DWnt2 protein is expressed where the concentration of Wg is low
or absent; that is where the tracheal placodes form and where the
cuticle secretes denticles (50). Thus, in wg embryos, where there
is no Wg protein and the denticles are continuous (20), one might
expect the tracheal placodes (51) and DWnt2 (Fig. 4C) expression
to form one continuous stripe and, indeed, they do.
This adventitious expression of DWnt2 in a broad domain in
wg embryos could compensate at least in part for the lack of wg
itself. Indeed, in these embryos, it must be mainly DWnt2 that
activates some sal and determines most or all of the DT found.
We could not detect any change in the pattern of wg RNA or
protein distribution in DWnt2 mutants.
DWnt Genes Vary in Effectiveness in Different Tissues. We assayed
the potency of DWnt2 and Wg in the tracheae: we took
DWnt2wg double mutants and added back each of the two
missing proteins in the normal pattern of expression for the wg
gene. We found that DWnt2 and Wg both rescued some DT in
the trachea (Fig. 5 B and D); however, only Wg can partially
rescue the various embryonic defects in morphology found in
wg embryos. When either DWnt2 or Wg is expressed locally in
the tracheal cells, each gives strong rescue, and more DT is made
(Fig. 5 A and C).
We also expressed the DWnt2 gene in wild-type embryos
either universally and strongly (arm VP16 Gal4) or in stripes
Fig. 2. Pattern of wg and DWnt2 expression with respect to Sal protein and
the tracheal cells. (A and B) Three tracheal metameres of a 1-eve-1 embryo at
stage 10 (A) or 12 (B) stained with a riboprobe for DWnt2 (green) and for Sal
(in red) and -Gal (blue) for the tracheal cells. Note that DWnt2 is expressed
near the tracheal cells during stage 10 (A) in cells that also express sal. (C and
D) Three tracheal metameres of a 1-eve-1 embryo at stage 10 (C) or 12 (D)
stained with a riboprobe for wg (green) and for Sal (in red) and -Gal (blue)
for the tracheal cells. (E) Two tracheal metameres of a 1-eve-1 embryo at stage
11 stained with a riboprobe for DWnt2 (green) and for Wg (red) and -Gal
(blue) for the tracheal cells. Note that wg and DWnt2 differ in their pattern of
expression. (F) Diagram summarizing the stainings in A–E. DWnt2 is expressed
in the dorsal ectoderm near the tracheal cells that is in the most dorsal
Sal-positive cells. wg expression alternates in stripes with Sal protein. Both
genes are produced near the tracheal cells.
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(ptcGal4), and in both cases, the tracheae are altered to the same
extent as when DWnt2 is expressed in the tracheal cells alone.
However, DWnt2 fails to alter the cuticle pattern (Fig. 4E),
whereas wg produces a naked cuticle phenotype (ref. 52; Fig.
4D). This lack of effect of DWnt2 on the epidermis is remarkable
as both the drivers used are strong and, when wg is driven, are
more than adequate to make a naked cuticle. Interestingly, when
DWnt2 is missexpressed in the eye, it also does not emulate the
phenotype produced by missexpression of wg (53). Moreover, the
effects of overexpressing DWnt2 in the ovary are stronger than
when overexpressing wg (54). All these results argue that the
tracheal cells and other tissues, including the epidermis, the eye,
and the ovary are differentially sensitive to the two DWnt
molecules, the trachea and the ovary being particularly respon-
sive to DWnt2.
There are several ways this difference could be achieved.
Perhaps DWnt2 does not act through the canonical Wnt pathway
in some tissues, such as the ectoderm or the eye. Perhaps DWnt2,
on its way to the tracheal cells, could be secreted or processed
differently. Perhaps the tracheal cells have something that allows
efficient presentation of the ligand to the Fz receptors, or they
lack a component that, in other tissues, impedes DWnt2 binding
or transduction. One possibility is that glucosaminoglycans help
breathless (btl, an FGF receptor expressed in tracheal cells; refs.
55–57) and are needed for Wnt signaling (58, 59). Maybe Btl
helps to gather or modify the heparan sulfate glucosaminogly-
cans, thereby altering the presentation of DWnt2 to the two
receptors, Fz and Dfz2. Whatever the explanation may be, the
tracheal cells are more responsive than other tissues to the
DWnt2 signal.
We next looked at the other DWnts. We drove DWnts5, -6, -8,
and -10 in the epidermis of wild-type embryos with one copy of
ptcGal4; none of these affected the cuticle pattern in a noticeable
way. The effects of expressing DWnt4 have been described above.
Are these DWnts able to affect tracheal development in the
wgDWnt2 double mutants? We added back each of these five
DWnts to either the tracheal cells themselves or in the pattern
of normal wg expression. We found that DWnts6 and -8 (Fig. 5
E and F) were each able to rescue DT partially, whereas -4, -5
(Fig. 5 G and H) and -10 did not. Note that DWnt6 and DWnt8
are not able to produce a tracheal phenotype when expressed in
tracheal cells of normal embryos, but they can do so in a
sensitized background.
Which DWnt Genes Help Make the DT? The results indicate that wg
and DWnt2 make the main contribution to DT formation, as the
absence of both genes completely eliminates DT in many cases.
However, traces of DT still are formed in about half the
hemisegments of wgDWnt2 embryos, indicating that contri-
butions of other genes might help. Also, rescue experiments
show that some other DWnts are able to activate the pathway. In
agreement with this result, we find that in most Df(2L)RF
DWnt2 embryos, all DT is missing, indicating that DWnt6
andor -4 andor -10 can compensate weakly for the absence of
Fig. 3. Tracheal requirements of wg andor DWnt2. (A–C) Lateral views of embryos at late stages of embryogenesis stained with mAb2A12 to highlight the
lumen of the tracheae. (A and B) wgDWnt2double mutants, the DT is missing (A) or very much reduced (arrow in B). The arrowhead in A points to an incomplete
VB. (C) DWnt2 combination, no tracheal defects are observed. Arrow points to DT. (D–I) Sal distribution at stages 12 (D–F) and 1415 (G–I) in lateral views of
embryos of the indicated genotypes. Note the absence of Sal in wgDWnt2 mutants (E, H, and Insets) as compared with WT (D, G, and Insets). Low levels of
Sal still are observed in wg mutants (F, I, and Insets). (J and K) dpp expression at stage 11 in lateral views of embryos of the indicated genotypes. (L and M) Kni
distribution at stage 1415 in lateral views of embryos of the indicated genotypes.
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wg and DWnt2. However, expression of DWnt6 and DWnt10 (15)
does not suggest that they act in tracheal development in the wild
type. DWnt4 is expressed in a similar pattern to that of wg (14)
but does not seem to assist wg during embryogenesis (9, 12). In
addition, none of DWnt4, -6, or -10 affected tracheal develop-
ment when expressed in tracheal cells of wild-type embryos.
Most likely, they produce traces of DT in the wgDWnt2
embryos, because those embryos offer a very sensitive test of
stimulation of the Wnt pathway. It remains unclear whether
these DWnts make any residual contribution to DT in the wild
type.
However, several observations suggest that DWnt2 contributes
to tracheal development in the wild-type fly. Notably, DWnt2 is
expressed near the tracheal cells at the appropriate stage, and
when overexpressed in tracheal cells, it mimics the effects of
overexpressing wg or a constitutively activated Arm. But, most
importantly, the phenotype of wgDWnt2 embryos indicate
that wg and DWnt2 together are responsible for virtually all DT
formation. Thus, DWnt2 probably cooperates with Wg or rein-
forces its main action.
Nevertheless, DWnt2 embryos do not show a visible tracheal
phenotype, indicating, at first sight, that the gene does not normally
contribute to DT formation. This lack of abnormality suggests that
wg alone (or with some help from different DWnts) is sufficient to
sponsor normal development in these mutant flies. Nevertheless, it
remains possible that DWnt2 could act in the wild-type. There are
at least two alternative hypotheses that could explain the lack of
tracheal phenotype in DWnt2 embryos.
First, the loss of DWnt2 could induce compensatory changes
in the amount, distribution, or activity of the other DWnts. As in
the case of DWnt6, -4, and -10 (see above), the expression of
DWnt5 (11, 16) and DWnt8 (its pattern of expression has not
been reported by others and we have detected expression only in
the CNS at early stages; our unpublished results) does not
suggest that they act in tracheal development, although we
cannot discard contributions under the level of detection. More-
over, although we have detected some small changes in the
expression of some DWnts in wg and wgDWnt2 embryos (e.g.,
the loss of DWnt5 expression in the labial segment at stage 10 as
well as loss of expression in lateral clusters of the thoracic
segments at stage 11), we have not detected any changes in the
pattern of expression that might account for any strong tracheal
rescue of DWnt2 embryos (our unpublished results). Therefore,
Fig. 4. (A and B) Lateral views of embryos of the indicated genotypes at late stages of embryogenesis stained with mAb2A12. Arrow in B points to the rescued
DT. (C) Pattern of DWnt2 expression in wg embryo at stage 10. (D and F) Dark field images of larval cuticle preparations of the indicated genotypes.
Overexpression of wg in the epidermis produces a naked cuticle phenotype, whereas overexpression of DWnt2 does not.
Fig. 5. Rescue of DT in double mutants by DWnt proteins. Lateral views of
embryos at late stages of embryogenesis stained with mAb2A12 to show the
trachea. Each image shows a wgDWnt2 double mutant in which the DWnt
indicated has been added in the pattern of the Gal4 line used. Note the rescue
of DT (arrows) when wg, DWnt2, or DWnt8 are added to the embryo (A–F).
Conversely, DWnt5 does not rescue the DT (G and H); the arrowhead in H
points to a piece of the VB.
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it is not clear how other DWnts could contribute to the complete
DT formation in DWnt2 embryos.
Second, let us suppose that all DWnts bind the receptor with
different affinities, with Wg binding most strongly. In the wild
type, the DWnts could compete, but Wg would be most effec-
tive—the contribution of DWnt2 to DT formation would be
minor. However, in embryos lacking Wg, mainly DWnt2 (which
is expressed in a broader domain in wg embryos and is not now
competing with Wg) could bind and partially substitute for Wg.
In the absence of DWnt2, Wg (and maybe other DWnts) would
have no competition from DWnt2 and would become even more
efficient, compensating for the contribution to DT formation
that DWnt2 has in the wild type. Finally, in the absence of both
Wg and DWnt2, other DWnts, even if they did not act in the wild
type, could now bind to the unoccupied receptors and have some
tiny effect on DT formation.
Complications of this kind may bedevil attempts to analyze the
precise wild type contributions of individual members of other
gene families.
Conclusions
We have presented evidence that DWnt2 can act in tracheal
development, whereas Wg acts in both developing epidermis and
trachea. The other five DWnts do little for the trachea. As with
the achaetescute homologues (which are alike in structure and
function but have different patterns of expression and, therefore,
act in different places; ref. 60), it may be that the DWnts are
preserved fundamentally because seven genes, even if they do
similar things, can be regulated in a more sophisticated way than
one. Perhaps, like DWnt2, they perform specialized tasks, acting
locally to help Wg in ways that could not be provided by any
additional regulatory control of wg itself. We also have shown
that, in at least this one case, tissues can have differential
sensitivity to specific homologues, a property that would allow
even more intricate forms of control.
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